Alyeska Investment Group, L.P. 13D/13G Filings for Kiora Pharmaceuticals, Inc. (KPRX)

Alyeska Investment Group, L.P. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
4:25 pm
Sale
2024-12-3113GKiora Pharmaceuticals, Inc.
KPRX
Alyeska Investment Group, L.P.75,628
2.500%
-180,780decrease
(-70.50%)
Filing
2024-11-14
4:32 pm
Purchase
2024-09-3013GKiora Pharmaceuticals, Inc.
KPRX
Alyeska Investment Group, L.P.256,408
8.400%
256,408increase
(New Position)
Filing